SCHEMBL19236791

SCHEMBL19236791

CCCCOC(=O)Cn1nc(C(N)=O)c2ccc(O)cc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.42
▸ KMT2A Q03164 5/20 0.42
▸ ESR1 P03372 4/20 0.41
▸ MAPT P10636 3/20 0.40
▸ CNR1 P21554 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ L3MBTL1 Q9Y468 3/20 0.39
▸ GAA P10253 2/20 0.39
▸ CFD P00746 1/20 0.39
▸ LMNA P02545 2/20 0.39
▸ TSHR P16473 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ NR1H2 P55055 1/20 0.39
▸ RNASEL Q05823 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ ALOX15 P16050 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19236960 0.84 MEN1 (0.46) MEN1KMT2AESR1MAPTCNR1
SCHEMBL24920126 0.83 KDM4E (0.44) KMT2AESR1MAPTGAACFD
SCHEMBL19236963 0.83 PSEN1 (0.42) MEN1KMT2AMAPTCNR1POLB
SCHEMBL19236962 0.81 MEN1 (0.41) MEN1KMT2AESR1MAPTCNR1
SCHEMBL29357130 0.81 LMNA (0.52) MEN1KMT2AMAPTCNR1POLB
SCHEMBL17026536 0.81 CFD (0.40) ESR1CFDALDH1A1
SCHEMBL17026562 0.78 CFD (0.44) KMT2AESR1CFDLMNA
SCHEMBL29781678 0.78 CFD (0.44) KMT2AESR1CFDLMNA
SCHEMBL19208509 0.76 TSHR (0.42) MEN1KMT2APOLBGAACFD
SCHEMBL19208600 0.75 TSHR (0.44) MEN1KMT2APOLBL3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017136395-A1 BENZOPYRAZOLE COMPOUNDS AND ANALOGUES THEREOF BIOCRYST PHARMACEUTICALS, INC. (US) 2017-08-10 — — WO disclosed
Send feedback